))
DME/Retina Edition: Top Headlines for Week of September 9, 2024
Manage episode 439584622 series 3560281
Innhold levert av Healio. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Healio eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
In this edition, enrollment and dosing complete in phase 1 trial of AIV007, popular benchmarks in clinical practice guidelines and more. Read the full coverage here:
Enrollment, dosing complete in phase 1 trial of AIV007 for AMD, diabetic macular edema
OCT, visual acuity popular benchmarks in clinical practice guidelines for DME
First patient dosed in phase 2 trial of EC-104 implant for diabetic macular edema
OCS-01 eye drop for DME in second stage of phase 3 trial
Q&A: Susvimo delivers immediate durability after implantation in wet AMD
References:
Crawford C. Update on OCS-01: A novel topical drop for DME in phase 3 trials. Presented at: Clinical Trials at the Summit; June 8, 2024; Park City, Utah.
Healio Interviews
McAllister M, et al. Assessing the strength of clinical practice guidelines for managing diabetic macular edema — A systematic literature review. Presented at: American Society of Retina Specialists annual meeting; July 17-20, 2024; Stockholm.
120 episoder
Del
